Organon & Co. (OGN) Balance Sheet
As of 2026-06-30 (10-Q), Organon & Co. (OGN) reported total assets of $13.2B, total liabilities of $12.2B and shareholders' equity of $1.0B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $1.1B. Long-term debt: $8.5B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OGNOrganon & Co.Follow OGN — free
—
Price chart with a free account
- Market cap
- 3.6B
- P/E TTM
- 17.6
- Dividend yield
- 0.6%
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.74 | 0.71 | 0.69 | 0.68 | 0.57 | 1.13 | |
| Receivables | 1.38 | 1.48 | 1.74 | 1.36 | 1.33 | 1.49 | |
| Inventory | 0.92 | 1.00 | 1.32 | 1.32 | 1.41 | 1.35 | |
| Current assets | 3.76 | 3.93 | 4.51 | 4.35 | 4.35 | 5.11 | |
| Total assets | 10.68 | 10.96 | 12.06 | 13.10 | 12.87 | 13.18 | |
| Current liabilities | 2.60 | 2.51 | 2.92 | 2.72 | 2.39 | 2.62 | |
| Long-term debt | 9.13 | 8.91 | 8.75 | 8.86 | 8.63 | 8.48 | |
| Short-term debt | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.07 | |
| Total liabilities | — | 11.85 | 12.13 | 12.63 | 12.12 | 12.17 | |
| Shareholders' equity | -1.51 | -0.89 | -0.07 | 0.47 | 0.75 | 1.01 |
USD billions · SEC XBRL
Organon & Co. — questions
- How much cash does Organon & Co. have?
- $1.1B in cash and cash equivalents as of 2026-06-30.
- How much debt does Organon & Co. have?
- $8.5B of long-term debt and $74.0M due within a year as of 2026-06-30.
- What are Organon & Co.'s total assets?
- $13.2B as of 2026-06-30.
- What is Organon & Co.'s shareholders' equity?
- $1.0B as of 2026-06-30.
Every figure on this page comes from Organon & Co.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.